Latest filing published 14 Feb 2025 for X4 Pharmaceuticals, Inc.
Filing timeline
BuySaleInsider track record
Paula Ragan: trading record in brief
This profile gathers the share dealings of Paula Ragan in X4 Pharmaceuticals, Inc, where the filings describe the role as chief executive. Over a trading history stretching from 13 March 2019 to 12 February 2025, the count stands at 52 filings.
The open-market record consists of 40 sales worth €1.1M, with no purchase. No amount is published for 4 filings, which the totals therefore leave out. The rest of the record consists of 12 share grants. Since January 2025: no purchases and 1 sale on the market.
The newest entry dates from 14 February 2025: a share grant, in X4 Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paula Ragan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,250,000 shares0Common StockSEC:0001628280-25-005700:0
- 76,473 shares@ US$0.4543.0% of flowCommon StockSEC:0001628280-25-002709:1
- 169,940 shares0Common StockSEC:0001628280-25-002709:0
- 31,897 shares@ US$0.39452.3% of flowCommon StockSEC:0001628280-24-048467:0
- 31,897 shares@ US$0.5623.2% of flowCommon StockSEC:0001628280-24-042941:0
- 239,436 shares@ US$0.549310.7% of flowCommon StockSEC:0001628280-24-042543:1
- 532,081 shares0Common StockSEC:0001628280-24-042543:0
- 49,678 shares@ US$0.88287.7% of flowCommon StockSEC:0001628280-24-010280:0
- 21,695 shares@ US$1.00913.9% of flowCommon StockSEC:0001628280-24-004266:0
- 39,906 shares@ US$0.903.0% of flowCommon StockSEC:0001628280-23-036796:1
- 199,531 shares@ US$0.7326.5% of flowCommon StockSEC:0001628280-23-036796:0
- 532,081 shares0Common StockSEC:0001628280-23-036462:0
- 6,724 shares@ US$1.922.3% of flowCommon StockSEC:0001628280-23-023440:0
- 6,724 shares@ US$2.232.6% of flowCommon StockSEC:0001628280-23-022469:0
- 6,292 shares@ US$1.952.2% of flowCommon StockSEC:0001628280-23-020355:0
- 49,678 shares@ US$0.847.6% of flowCommon StockSEC:0001628280-23-007720:0
- 21,695 shares@ US$0.933.6% of flowCommon StockSEC:0001628280-23-003755:0
- 13,448 sharesCommon StockSEC:0001628280-22-023324:0
- 6,724 sharesCommon StockSEC:0001628280-22-018043:0
- 6,724 sharesCommon StockSEC:0001628280-22-017436:0
- 6,292 shares@ US$1.211.4% of flowCommon StockSEC:0001628280-22-016336:0
- 220,789 shares0Common StockSEC:0001628280-22-004517:0
- 21,695 sharesCommon StockSEC:0001628280-22-002506:0
- 13,448 shares@ US$5.1011.3% of flowCommon StockSEC:0001628280-21-017331:0
- 13,448 shares@ US$5.7812.7% of flowCommon StockSEC:0001628280-21-013959:0
25 of 52 declarations
